Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

182.69
-6.4600-3.42%
Post-market: 182.690.00000.00%19:36 EDT
Volume:827.04K
Turnover:152.69M
Market Cap:11.25B
PE:-31.28
High:189.26
Open:189.26
Low:182.55
Close:189.15
52wk High:198.00
52wk Low:95.49
Shares:61.56M
Float Shares:58.65M
Volume Ratio:0.83
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8403
EPS(LYR):-5.8403
ROE:-8.47%
ROA:5.38%
PB:2.60
PE(LYR):-31.28

Loading ...

Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Correspondence

Form CORRESP - Correspondence
Jul 25, 2025

Major Issues Report

Form 8-K - Current report
Jul 10, 2025

Major Issues Report

Form 8-K - Current report
Jul 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Apr 08, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Correspondence

Form CORRESP - Correspondence
Apr 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]